The prevalence of BRCA1 mutations among young women with triple-negative breast cancer

BACKGROUND: Molecular screening for BRCA1 and BRCA2 mutations is now an established component of risk evaluation and management of familial breast cancer. Features of hereditary breast cancer include an early age-of-onset and over-representation of the 'triple-negative' phenotype (negative...

Descripción completa

Detalles Bibliográficos
Autores principales: Young, SR, Pilarski, Robert T, Donenberg, Talia, Shapiro, Charles, Hammond, Lyn S, Miller, Judith, Brooks, Karen A, Cohen, Stephanie, Tenenholz, Beverly, DeSai, Damini, Zandvakili, Inuk, Royer, Robert, Li, Song, Narod, Steven A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666759/
https://www.ncbi.nlm.nih.gov/pubmed/19298662
http://dx.doi.org/10.1186/1471-2407-9-86

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2666759/
https://www.ncbi.nlm.nih.gov/pubmed/19298662
http://dx.doi.org/10.1186/1471-2407-9-86

Ejemplares similares